This review consolidates existing evidence, highlighting that elevated FSP1 often marks aggressive forms of liver, colorectal, pancreatic, gastric, breast, lung, and blood cancers. The gene discussed is AIFM2; the disease is hematopoietic and lymphoid system neoplasm.